Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Clinical Rheumatology

• Publication date

  2011-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10067-010-1647-4PMID 21161669
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• More stories on Th17 cells

  2009cited by this paper
• Increased serum interleukin 17 in patients with systemic lupus erythematosus

  2009cited by this paper
• Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis.

  2009influential reference
• Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis.

  2009influential reference
• Expression of IL-23 and IL-17 and effect of IL-23 on IL-17 production in ankylosing spondylitis

  2009cited by this paper
• IL-17 and Th17 cells in human inflammatory diseases.

  2009cited by this paper
• Loss of IFN-γ Enables the Expansion of Autoreactive CD4+ T Cells to Induce Experimental Autoimmune Encephalomyelitis by a Nonencephalitogenic Myelin Variant Antigen1

  2008cited by this paper
• Intracytoplasmic Cytokine Expression and T Cell Subset Distribution in the Peripheral Blood of Patients with Ankylosing Spondylitis

  2008cited by this paper
• The IL23R Arg381Gln non-synonymous polymorphism confers susceptibility to ankylosing spondylitis

  2008cited by this paper
• TH-17 cells in the circle of immunity and autoimmunity

  2007cited by this paper
• Protective role of IFN‐γ in collagen‐induced arthritis conferred by inhibition of mycobacteria‐induced granulocyte chemotactic protein‐2 production

  2007cited by this paper
• Transcriptional regulation of Th17 cell differentiation.

  2007cited by this paper
• Serum IL-17, BMP-7, and bone turnover markers in patients with ankylosing spondylitis.

  2007cited by this paper
• Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation.

  2007cited by this paper
• Cutting Edge: IL-23 Cross-Regulates IL-12 Production in T Cell-Dependent Experimental Colitis1

  2006cited by this paper
• Cutting edge: IL-23 cross-regulates IL-12 production in T cell-dependent experimental colitis.

  2006cited by this paper
• Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

  2005cited by this paper
• Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin

  2005cited by this paper
• IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

  2005cited by this paper
• Clinical features of adult-onset ankylosing spondylitis in Korean patients: patients with peripheral joint disease (PJD) have less severe spinal disease course than those without PJD.

  2004cited by this paper
• Evolving concepts of rheumatoid arthritis

  2003cited by this paper
• Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation

  2003cited by this paper
• High Levels of IL-17 in Rheumatoid Arthritis Patients: IL-15 Triggers In Vitro IL-17 Production Via Cyclosporin A-Sensitive Mechanism1

  2000cited by this paper
• A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index.

  1994cited by this paper
• Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

  1984cited by this paper

• Recent advances in biologic therapies for ankylosing spondylitis: A 2024 update.

  2026cites this paper
• Current status and emerging trends in biological therapies for ankylosing spondylitis: A bibliometric analysis (2004–2024)

  2026cites this paper
• Exploratory Cytokine and Bone-Marker Patterns in a Proteoglycan-Induced Spondyloarthritis Mouse Model: Th1/Th2 Strain Comparison and TLR2/3/4 Knockout Readouts

  2026cites this paper
• Breaking boundaries in ankylosing spondylitis: how innovative cell therapies reshape immunity, drive cutting-edge advances, and face future challenges

  2025cites this paper
• The Causal Relationships and Therapeutic Targets of Plasma Proteins in Ankylosing Spondylitis

  2025cites this paper
• Biomarkers for successful tapering of a tumor necrosis factor inhibitor in patients with radiographic axial spondyloarthritis: A pilot study

  2025cites this paper
• Ankilozan Spondilit Hastalarında Serum IL-17 ve TNF-Alfa Düzeyi ile Hastalık Aktivitesi Arasındaki İlişki

  2025cites this paper
• A Bidirectional Mendelian Randomization Study Investigating the Causal Relationship Between Ankylosing Spondylitis and Chronic Obstructive Pulmonary Disease

  2025cites this paper
• Safety, pharmacokinetics, preliminary efficacy, pharmacodynamics, and immunogenicity of QX002N, an anti-IL-17A monoclonal antibody, after short-term treatment of active ankylosing spondylitis

  2025cites this paper
• IL-23/IL-17 axis in the pathogenesis and therapy of axial spondyloarthritis associated with inflammatory

  2025cites this paper
• Comprehensive overview of alternative medicine in the treatment of ankylosing spondylitis: Symptoms, pathogenesis, diagnosis and treatments (Review)

  2025cites this paper
• IL-17A in psoriatic arthritis: mechanistic insights, clinical implications, and advances in therapeutic strategies

  2025cites this paper
• Guardians on call: neutrophils, macrophages and dendritic cells in arthritis pathogenesis

  2025cites this paper
• Interleukin-17 and interleukin-23 cytokine profiles in palindromic rheumatism: potential therapeutic targets and prognostic biomarkers for disease progression to rheumatoid arthritis

  2025cites this paper
• Causal relationship between Faecalibacterium abundance and risk of Faecalibacterium-related diseases: a two-sample bi-directional Mendelian randomisation study.

  2025cites this paper
• Exploration of molecular biomarkers in ankylosing spondylitis transcriptomics

  2024cites this paper
• Targeted therapies for uveitis in spondyloarthritis: a narrative review.

  2024cites this paper
• The causal relationship between immune cells and ankylosing spondylitis: a bidirectional Mendelian randomization study

  2024cites this paper
• Investigating potential novel therapeutic targets and biomarkers for ankylosing spondylitis using plasma protein screening

  2024cites this paper
• IL-17 inhibitors in axial spondyloarthritis. An overview

  2024cites this paper
• Sex dimorphism of IL-17-secreting peripheral blood mononuclear cells in ankylosing spondylitis based on bioinformatics analysis and machine learning

  2024cites this paper
• The role of ixekizumab in the treatment of nonradiographic axial spondyloarthritis.

  2024cites this paper
• Serum IL-23 levels reflect a myeloid inflammatory signature and predict the response to apremilast in patients with psoriatic arthritis

  2024cites this paper
• The management of axial spondyloarthritis with cutting-edge therapies: advancements and innovations

  2024cites this paper
• Role of the Gut Microbiota in Osteoarthritis, Rheumatoid Arthritis, and Spondylarthritis: An Update on the Gut–Joint Axis

  2024cites this paper
• A case report of primary biliary cholangitis combined with ankylosing spondylitis

  2023cites this paper
• Value of ischemia-modified albumin in ankylosing spondylitis

  2023cites this paper
• The Expression of the Alpha7 Nicotinic Acetylcholine Receptor and the Effect of Smoking in Curdlan-Administered SKG Mice

  2023cites this paper
• Genetic risk factors in ankylosing spondylitis: Insights into etiology and disease pathogenesis

  2023cites this paper
• Aryl hydrocarbon receptor gene expression in ankylosing spondylitis and its correlation with interleukin-17, RAR-related orphan receptor gamma t expression, and disease activity indices

  2023cites this paper
• An Important Role in Novel Immune Mechanism and Diagnostic Model of Ankylosing Spondylitis: The CeRNA-ADRB2 Network

  2023cites this paper
• Recent advances in uveitis therapy: focus on selected phase 2 and 3 clinical trials

  2023cites this paper
• Updates on ankylosing spondylitis: pathogenesis and therapeutic agents

  2023cites this paper
• Have Therapeutics Enhanced Our Knowledge of Axial Spondyloarthritis?

  2023cites this paper
• Trained immunity in human monocyte enhances myeloid-T-cell pathogenic crosstalk in Ankylosing Spondylitis

  2023cites this paper
• Correlation of serum subfatin, cthrc1, ctrp3, ctrp6 levels with disease indices in patients with axial spondyloarthritis

  2023cites this paper
• Tenascin-C and Interleukin-17 Up-regulation in Axial Spondyloarthritis Patients

  2023cites this paper
• FOXO3a Alleviates the Inflammation and Oxidative Stress via Regulating TGF-β and HO-1 in Ankylosing Spondylitis

  2022cites this paper
• Inhibiting IL-17A and IL-17F in Rheumatic Disease: Therapeutics Help to Elucidate Disease Mechanisms

  2022cites this paper
• Increased proportions of inflammatory T cells and their correlations with cytokines and clinical parameters in patients with ankylosing spondylitis from northern Sweden

  2022cites this paper
• The genetic backbone of ankylosing spondylitis: how knowledge of genetic susceptibility informs our understanding and management of disease

  2022cites this paper
• The Potential Role of Genetics, Environmental Factors, and Gut Dysbiosis in the Aberrant Non-Coding RNA Expression to Mediate Inflammation and Osteoclastogenic/Osteogenic Differentiation in Ankylosing Spondylitis

  2022cites this paper
• Upregulation of Unfolded Protein Response and ER Stress–Related IL-23 Production in M1 Macrophages from Ankylosing Spondylitis Patients

  2022cites this paper
• Randomized double-blinded controlled trial on the effect of synbiotic supplementation on IL-17/IL-23 pathway and disease activity in patients with axial spondyloarthritis

  2022cites this paper
• No Significant Effects of IL-23 on Initiating and Perpetuating the Axial Spondyloarthritis: The Reasons for the Failure of IL-23 Inhibitors

  2022cites this paper
• Metallothionein-1 is Positively Correlated with Inflammation and Ankylosing Spondylitis Activity

  2022cites this paper
• Association of Serum Interleukin-17 and Interleukin-23 Levels with Disease Activity, Function, Mobility, Enthesitis Index in Patients with Ankylosing Spondylitis

  2022cites this paper
• Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview

  2021cites this paper
• Inflammatory Foot Involvement in Spondyloarthritis: From Tarsitis to Ankylosing Tarsitis

  2021cites this paper
• Elevated Th17 cells are associated with cardiovascular complications in ankylosing spondylitis.

  2021cites this paper
• Efficacy and safety of interleukin‐17 inhibitors in the treatment of chronic rheumatic diseases: A combined and updated meta‐analysis

  2021cites this paper
• Innate Immune-Related Cells and Cytokines in Spondyloarthropathies

  2021cites this paper
• B Cell Involvement in the Pathogenesis of Ankylosing Spondylitis

  2021cites this paper
• ‘All disease begins in the gut’—the role of the intestinal microbiome in ankylosing spondylitis

  2021cites this paper
• Efficacy and safety of interleukin-17A inhibitors in patients with ankylosing spondylitis: a systematic review and meta-analysis of randomized controlled trials

  2021cites this paper
• Treatment of Connective Tissue Disease-Related Intractable Disease with Biological Therapeutics

  2021cites this paper
• Safety of secukinumab for the treatment of active ankylosing spondylitis

  2021influential citation
• Evolution of cytokine production capacity in ancient and modern European populations

  2021cites this paper
• Increased Proportion of TH17, TH22 and TC22 Cells and Correlations to IL-22, IL-10 and Clinical Parameters in a Cohort of Patients With Ankylosing Spondylitis From Northern Sweden.

  2021influential citation
• Influence of IL10 (rs1800896) Polymorphism and TNF-α, IL-10, IL-17A, and IL-17F Serum Levels in Ankylosing Spondylitis

  2021cites this paper
• Immunomodulation with IL-17 and TNF-α in spondyloarthritis: focus on the eye and the central nervous system

  2021cites this paper
• Exploring IL-17 in spondyloarthritis for development of novel treatments and biomarkers.

  2021cites this paper
• Recent Updates in Juvenile Spondyloarthritis.

  2021cites this paper
• Upmodulation of Unfolded Protein Response and ER Stress-Related IL-23 Production in M1 Macrophages From Ankylosing Spondylitis Patients

  2021cites this paper
• Similarities and Differences Between Juvenile and Adult Spondyloarthropathies

  2021cites this paper
• Update: enteropathische Spondyloarthritis

  2021cites this paper
• Interleukin-17A Interweaves the Skeletal and Immune Systems

  2021cites this paper
• Potential Role and Impact of Peripheral Blood Mononuclear Cells in Radiographic Axial Spondyloarthritis-Associated Endothelial Dysfunction

  2021cites this paper
• Polymorphisms within Genes Coding for IL-17A and F and Their Receptor as Clinical Hallmarks in Ankylosing Spondylitis

  2021cites this paper
• OARRR_A_328211 293..303

  2021cites this paper
• Recent Updates in the Immunopathology of Type 3 Immunity-Mediated Enthesitis

  2021cites this paper
• Spondyloarthritis patients with and without intestinal symptoms – searching for discriminating biomarkers

  2020cites this paper
• Aptamers for Proteins Associated with Rheumatic Diseases: Progress, Challenges, and Prospects of Diagnostic and Therapeutic Applications

  2020influential citation
• Gut Microbiome and Its Interaction with Immune System in Spondyloarthritis

  2020cites this paper
• Short-Term Efficacy and Safety of Secukinumab for Ankylosing Spondylitis: A Systematic Review and Meta-Analysis of RCTs

  2020cites this paper
• New insights into IL-17/IL-23 signaling in ankylosing spondylitis (Review)

  2020cites this paper
• Pain and Fatigue in Patients With Ankylosing Spondylitis Treated With Tumor Necrosis Factor Inhibitors

  2020cites this paper
• Immunohistochemical detection of IL-17 and IL-23 improves the identification of patients with a possible diagnosis of Sjogren's syndrome.

  2020cites this paper
• Copy number variation of IL17RA gene and its association with the ankylosing spondylitis risk in Iranian patients: a case-control study

  2020cites this paper
• Biomarker development for axial spondyloarthritis

  2020cites this paper
• New developments in our understanding of ankylosing spondylitis pathogenesis

  2020cites this paper
• The Role of the IL-23/IL-17 Pathway in the Pathogenesis of Spondyloarthritis

  2020cites this paper
• Toxicological considerations in the treatment of axial spondylo-arthritis

  2020cites this paper
• Molecular mechanisms and clinical studies of iguratimod for the treatment of ankylosing spondylitis

  2020cites this paper
• Circulating interleukin-23 levels in ankylosing spondylitis and their correlation with disease activity

  2020influential citation
• Oxidative stress-mediated mitochondrial dysfunction facilitates mesenchymal stem cell senescence in ankylosing spondylitis

  2020cites this paper
• Risk of ankylosing spondylitis following human papillomavirus infection: A nationwide, population-based, cohort study.

  2020cites this paper
• IL-23 induces the expression of pro-osteogenic factors in osteoclasts

  2020cites this paper
• miR-214 stimulated by IL-17A regulates bone loss in patients with ankylosing spondylitis.

  2019cites this paper
• H19 Increases IL-17A/IL-23 Releases via Regulating VDR by Interacting with miR675-5p/miR22-5p in Ankylosing Spondylitis

  2019cites this paper
• Serological Biomarkers in Early Axial Spondyloarthritis During 24-Months Follow Up (Italian Arm of Space Study)

  2019cites this paper
• Ankylosing spondylitis: etiology, pathogenesis, and treatments

  2019cites this paper
• Implication of IL-17 in Bone Loss and Structural Damage in Inflammatory Rheumatic Diseases

  2019cites this paper
• Effect of biologics in the level of cytokines in the synovial fluid of patients with ankylosing spondylitis

  2019influential citation
• Serum Interleukin-23/17 Levels in Ankylosing Spondylitis Patients Treated with Nonsteroidal Anti-Inflammatory Drugs: A Prospective Cohort Study

  2019cites this paper
• Successful adalimumab treatment and usefulness of capsule endoscopy for gut inflammation concomitant with ankylosing spondylitis

  2019cites this paper
• Advancing research paradigms and pathophysiological pathways in psoriatic arthritis and ankylosing spondylitis: Proceedings of the 2017 Platform for the Exchange of Expertise and Research (PEER) meeting.

  2019cites this paper
• Primary efficacy of netakimab, a novel interleukin-17 inhibitor, in the treatment of active ankylosing spondylitis in adults.

  2019cites this paper
• The correlation between intestinal dysbiosis and the development of ankylosing spondylitis.

  2019cites this paper
• Evaluation of ERAP1 gene single nucleotide polymorphisms in immunomodulation of pro-inflammatory and anti-inflammatory cytokines profile in ankylosing spondylitis.

  2019cites this paper